Haystack Oncology News and Activities

Headquarters: United States (USA)

Haystack Oncology is owned by Quest Diagnostics.

Quest Diagnostics is one of the...

Quest Diagnostics is a company listed under the stock ticker DGX (US).

Quest Diagnostics has a direct presence in 4 countries.

Quest Diagnostics has 6 subsidiaries including Centogene, Foresight Diagnostics and Haystack Oncology.

They are in:

Acquisition, funding and merger involving Quest Diagnostics.

View the org chart displaying its 14 main executives

Timothy Wentworth has joined the company as Director (posted on March 13 2026).
Benjamin Beauvalot has joined the company as Senior Vice President, Chief Strategy and Mergers and Acquisitions Officer (posted on February 26 2026).

Create your alert
to follow the executive moves at Haystack Oncology.

IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
Rallybio and Avenzo Therapeutics have announced they will merge (posted on June 1 2026)..

The best decision-maker directory

Discover the organization charts of your favorite companies.

Spot the influential executives using our search tools.

Receive notifications when executive positions change.

Fuel your company's success with our real-time data.

Individual Access

Data & API

Executives

Companies

The Official Board